Published on
June 25, 2026
- 23:09 GMT
eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery
Total non-dilutive funding awarded to eXoZymes is now almost $20 million, validating the scalable nature of the Company’s platform eXoZymes Inc. (NASDAQ:EXOZ) LOS ANGELES, CA, UNITED STATES, June 25, 2026 /EINPresswire.com/ -- eXoZymes Inc. ( …
Distribution channels:
Business & Economy, Consumer Goods
...
